ESC Professional Premium Access

Thrombosis and anticoagulation in valvular heart disease

Event: ESC Congress 2022
Topic: Valvular Heart Disease
Session type: Moderated ePosters
Date: 28 August 2022
Time: 08:15 - 08:45

Congress Session

5 presentations in this session

To compare efficacy and safety of direct oral anticoagulants in patients with concurrent atrial fibrillation and bioprosthetic heart valve repair or replacement: a systematic review and meta-analysis

Speaker: Doctor A. Kaur (New York City, US)
Thumbnail

Oral anticoagulant treatment in patients with atrial fibrillation early after valvular intervention: a nationwide cohort study

Speaker: Associate Professor C. Christersson (Uppsala, SE)
Thumbnail

Comparing direct oral anticoagulants versus vitamin k antagonist in patients with atrial fibrillation after transcatheter aortic valve replacement: an updated meta-analysis

Speaker: Doctor A. Kaur (New York City, US)
Thumbnail

Risk factors and clinical effects of late leaflet thrombosis after transcatheter aortic valve replacement

Speaker: Doctor M. Bak (Seoul, KR)
Thumbnail

Hypoattenuated leaflet thickening is associated with silent brain injury

Speaker: Doctor A. Nagy (Budapest, HU)
Thumbnail

5 speakers from this session

Doctor Arpanjeet Kaur

Icahn School of Medicine at Mount Sinai Morningside West, New York City (United States of America)
0 follower

Associate Professor Christina Christersson

Uppsala University, Uppsala (Sweden)
2 presentations
0 follower

Doctor Arpanjeet Kaur

Icahn School of Medicine at Mount Sinai Morningside West, New York City (United States of America)
0 follower

Doctor Minjung Bak

Samsung Medical Center, Seoul (Korea (Republic of))
0 follower

Doctor Aniko Iiona Nagy

Semmelweis University Heart and Vascular Center, Budapest (Hungary)
0 follower

This platform is supported by

logo Novo Nordisk